Palomino Labs Reports Q1 Losses, Secures $17M in New Funding
Tom Rudovsky · Reported by Wiseek News
More coverage: Building Materials Stocks · Materials
Sentiment
Neutral
Importance
8
Price
0
Mkt Cap
0
52W Low
0
52W High
0
52W Position
Off High
Rel. Volume
Market data snapshot near publication time
Summary
Palomino Laboratories Inc. reported its first-quarter 2026 results, showing no revenue and a net loss of $1.24 million, or $(0.07) diluted EPS. While the company remains in a development stage with ongoing losses, a significant private placement completed in April 2026 raised $16.98 million. This capital infusion is critical, providing the company with sufficient funding to cover operations for at least one year. The financing addresses immediate liquidity concerns for the recently public company, allowing it to continue advancing its microLED optoelectronic platform and R&D efforts.
This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.
Price Chart
PALX - Latest Insights
PALX
Aug 05, 2026, 11:16 AM EDT
Price at Filing:
$13.35
Real-time Price:
$13.35
Change:
$0 (0%)
Market Cap:
N/A
PALX
Aug 04, 2026, 6:35 PM EDT
Price at Filing:
$13.25
Real-time Price:
$13.35
Change:
+$0.100 (+0.75%)
Market Cap:
N/A
PALX
Jul 16, 2026, 3:56 PM EDT
Price at Filing:
$7.35
Real-time Price:
$13.35
Change:
+$6.00 (+82%)
Market Cap:
N/A
PALX
Jul 16, 2026, 7:00 AM EDT
Price at Filing:
$5.90
Real-time Price:
$13.35
Change:
+$7.45 (+126%)
Market Cap:
N/A